Skip to main content
Top
Published in: Clinical and Translational Oncology 12/2013

01-12-2013 | Editorial

SEOM Guidelines 2013: a response to the needs of Spanish oncologists

Authors: J. J. Cruz-Hernández, C. A. Rodríguez

Published in: Clinical and Translational Oncology | Issue 12/2013

Login to get access

Excerpt

In this issue of Clinical and Translational Oncology, the Spanish Society of Clinical Oncology (SEOM) publishes the fourth part of the SEOM’s Clinical Practice Guidelines. First guidelines were published in 2010, and 3 years later the scientific committee and the executive board of the Spanish Society of Clinical Oncology have found necessary to publish an updated edition of some of the early guides reported, dedicated to different tumors in which the continuous changes that have taken place in the medical treatment of cancer made necessary a deep review [18]. Similarly, the guide for the treatment of emesis induced by chemotherapy has been updated [9], and the guide for the treatment of osteosarcoma has also been incorporated [10]. …
Literature
1.
go back to reference Camps C, Felip E, García-Campelo R, Trigo JM, Garrido P. SEOM Clinical Guidelines for the treatment of non-small cell lung cancer. Clin Transl Oncol. 2013. doi:10.1007/s12094-013-1085-2. Camps C, Felip E, García-Campelo R, Trigo JM, Garrido P. SEOM Clinical Guidelines for the treatment of non-small cell lung cancer. Clin Transl Oncol. 2013. doi:10.​1007/​s12094-013-1085-2.
3.
go back to reference Maurel J, Grávalos C, Rivera F, Vera R, González E. SEOM Clinical Guidelines for the adjuvant treatment of colorectal cancer. Clin Transl Oncol. 2013. doi:10.1007/s12094-013-1083-4. Maurel J, Grávalos C, Rivera F, Vera R, González E. SEOM Clinical Guidelines for the adjuvant treatment of colorectal cancer. Clin Transl Oncol. 2013. doi:10.​1007/​s12094-013-1083-4.
4.
go back to reference Casado E, Feliu J, Gomez MA, Sanchez-Gastaldo A, García-Carbonero R. SEOM Clinical Guidelines for the treatment of advanced colorectal cancer. Clin Transl Oncol. 2013. doi:10.1007/s12094-013-1082-5. Casado E, Feliu J, Gomez MA, Sanchez-Gastaldo A, García-Carbonero R. SEOM Clinical Guidelines for the treatment of advanced colorectal cancer. Clin Transl Oncol. 2013. doi:10.​1007/​s12094-013-1082-5.
6.
go back to reference Del Barco S, Ciruelos E, Tusquets I, Ruiz M, Barnadas A. SEOM Clinical Guidelines for the systemic treatment of early breast cancer. Clin Transl Oncol. 2013. doi:10.1007/s12094-013-1084-3. Del Barco S, Ciruelos E, Tusquets I, Ruiz M, Barnadas A. SEOM Clinical Guidelines for the systemic treatment of early breast cancer. Clin Transl Oncol. 2013. doi:10.​1007/​s12094-013-1084-3.
9.
go back to reference García-Gómez J, Pérez ME, Alonso M, Escobar Y, García Mata J. SEOM Clinical Guidelines to antiemetic prophylaxis in cancer patients treated with chemotherapy. Clin Transl Oncol. 2013. doi:10.1007/s12094-013-1093-2. García-Gómez J, Pérez ME, Alonso M, Escobar Y, García Mata J. SEOM Clinical Guidelines to antiemetic prophylaxis in cancer patients treated with chemotherapy. Clin Transl Oncol. 2013. doi:10.​1007/​s12094-013-1093-2.
11.
go back to reference DeMartino JK, Larsen JK. Equity in cancer care: pathways, protocols, and guidelines. J Natl Compr Canc Netw. 2012;10(Suppl 1):S1–9.PubMed DeMartino JK, Larsen JK. Equity in cancer care: pathways, protocols, and guidelines. J Natl Compr Canc Netw. 2012;10(Suppl 1):S1–9.PubMed
Metadata
Title
SEOM Guidelines 2013: a response to the needs of Spanish oncologists
Authors
J. J. Cruz-Hernández
C. A. Rodríguez
Publication date
01-12-2013
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 12/2013
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-013-1097-y

Other articles of this Issue 12/2013

Clinical and Translational Oncology 12/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine